PATENT CLAIM ANALYSIS

Application Number: 16104610
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["424", "172100"]

Abstract:
There is provided antibodies or antigen-binding fragments, derivatives or variants thereof which are capable of binding to the FBG domain of tenascin-C. There are also provided uses of such antibodies or antigen-binding fragments, derivatives or variants thereof, as well as methods of identifying such antibodies.

Claim (Index 90):
A composition comprising an antibody or binding fragment of claim  1  and a pharmaceutically acceptable carrier, excipient and/or diluent.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 96.0
- Lexical Diversity: 1.72414
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15501979', '15358173', '13140492', '14449478', '13577104']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6759345539038936
- 35 USC 102 Novelty (BERT): 0.6432248646910801
- Combined Prediction Score: 0.6726635849826123
- Mean Citation Score: 372.140408
- Max Citation Score: 644.1617
- Similarity Product: 551.3495876327573

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test